Although recent cohort studies suggest a possible survival benefit for prophylactic mastectomy in unaffected BRCA1 carriers, there are no data to suggest a survival benefit relative to MRI surveillance in unaffected BRCA2/PALB2 carriers or carriers with a prior history of breast cancer. The gene discussed is BRCA2; the disease is breast carcinoma.